FDA Approves Merus’ Bizengri for Advanced Pancreatic and Lung Cancers
FDA (The U.S. Food and Drug Administration) has granted accelerated approval to Merus N.V.’s bispecific antibody, Bizengri (zenocutuzumab-zbco), for the…
Clinical Trial
Read More
Neurocrine Biosciences Takes Bold Step to Refocus Efforts After Clinical Trial Setback, Reinforcing Commitment to Mental Health Innovation
Neurocrine Biosciences Halts Development of Schizophrenia Drug After Trial Failure Neurocrine Biosciences, in a significant setback, has announced that it…